Cardiovascular consequences of obstructive sleep apnea

Current Opinion in Cardiology

Volumn 31, Issue 6, 2016, Pages 599-605

  Ayas, Najib T ^a   Taylor, Carolyn M ^a   Laher, Ismail ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiovascular disease; Endothelial dysfunction; Obstructive sleep apnea; Oxidative stress; Treatment

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CATECHOLAMINE; COPEPTIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; ISCHEMIA MODIFIED ALBUMIN; ISOPROSTANE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; NITRIC OXIDE; NORADRENALIN;

ACUTE CORONARY SYNDROME; AORTA DISSECTION; ARTERIAL WALL THICKENING; ATRIAL FIBRILLATION; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INFLAMMATION; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; COMPLICATION; PHYSIOLOGY;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HEART FAILURE; HUMANS; HYPERTENSION; SLEEP APNEA, OBSTRUCTIVE;

EID: 84988600922     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000329     Document Type: Review

References (37)

1. Badran M, Yassin BA, Fox N, et al. Epidemiology of sleep disturbances and cardiovascular consequences. Can J Cardiol 2015; 31:873-879.
2. Schillaci G, Battista F, Fiorenzano G, et al. Obstructive sleep apnea and cardiovascular disease-a new target for treatment. Curr Pharm Des 2015; 21:3496-3504.
3. Hoyos CM, Melehan KL, Liu PY, et al. Does obstructive sleep apnea cause endothelial dysfunction? A critical review of the literature. Sleep Med Rev2015; 20:15-26.
4. Schoen T, Hohmann E-M, Van Der Lely S, et al. Plasma copeptin levels and ambulatory blood pressure characteristics in healthy adults. J Hypertens 2015; 33:1571-1579.
5. Parra O, Arboix A. Stroke and sleep-disordered breathing: a relationship under construction. World J Clin Cases 2016; 4:33-37.
6. Parra O, Sánchez-ArmengolÁ, Capote F, et al. Efficacy of continuous positive airway pressure treatment on 5-year survival in patients with ischaemic stroke and obstructive sleep apnea: a randomized controlled trial. J Sleep Res 2015; 24:47-53.
7. Nishihata Y, Takata Y, Usui Y, et al. Continuous positive airway pressure treatment improves cardiovascular outcomes in elderly patients with cardiovascular disease and obstructive sleep apnea. Heart Vessels 2015; 30:61-69.
8. Qian Y, Yi H, Meng L, et al. Independent association between sleep fragmentation and dyslipidemia in patients with obstructive sleep apnea. Sci Rep 2016; 6:26089.
9. Parati G, Lombardi C, Castagna F, et al. Heart failure and sleep disorders. Nat Rev Cardiol 2016; 13:389-403.
10. Daiber A, Steven S, Weber A, et al. Targeting vascular (endothelial) dysfunction. Br J Pharmacol 2016. [Epub ahead of print]
11. Hoyos CM, Melehan KL, Liu PY, et al. Does obstructive sleep apnea cause endothelial dysfunction? A critical review of the literature. Sleep Med Rev 2015; 20:15-26.
12. Muñ oz-Hernandez R, Vallejo-Vaz AJ, Sanchez-Armengol A, et al. Obstructive sleep apnoea syndrome, endothelial function and markers of endothelialization. Changes after CPAP. PLoS One 2015; 10:e0122091.
13. Lu C-H, Lin H-C, Huang C-C, et al. Increased circulating endothelial progenitor cells and antioxidant capacity in obstructive sleep apnea after surgical treatment. Clin Chim Acta 2015; 448:1-7.
14. Kanbay A, Ceylan E, Inö nü Köseoǧlu H, et al. Endocan: a novel predictor of endothelial dysfunction on obstructive sleep apnea. Clin Respir J 2016. [Epub ahead of print]
15. Altintas N, Mutlu LC, Akkoyun AC, et al. Effect of CPAP on new endothelial dysfunction marker, endocan, in people with obstructive sleep apnea. Angiology 2016; 67:364-374.
16. Eisele H-J, Markart P, Schulz R. Obstructive sleep apnea, oxidative stress and cardiovascular disease: evidence from human studies. Oxid Med Cell Longev 2015; 2015:608438.
17. Karamanli H, Kiyici A, Arik B, et al. Influence of obstructive sleep apnea on ischemia-modified albumin levels and carotid intima-media thickness. J Investig Med 2016; 64:1035-1041.
18. Fatureto-Borges F, Lorenzi-Filho G, Drager LF. Effectiveness of continuous positive airway pressure in lowering blood pressure in patients with obstructive sleep apnea: a critical review of the literature. Integr Blood Press Control 2016; 9:43-47.
19. Bratton DJ, Gaisi T, Wons AM, et al. CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis. JAMA 2015; 314:2280-2293.
20. Sanchez-de-la-Torre M, Khalyfa A, Sanchez-de-la-Torre A, et al. Precision medicine in patients with resistant hypertension and obstructive sleep apnea: blood pressure response to continuous positive airway pressure treatment. J Am Coll Cardiol 2015; 66:1023-1032.
21. Lin X, Chen G, Qi J, et al. Effect of continuous positive airway pressure on arterial stiffness in patients with obstructive sleep apnea and hypertension: a meta-analysis. Eur Arch Otorhinolaryngol 2016. [Epub ahead of print]
22. Furlan SF, Braz CV, Lorenzi-Filho G, et al. Management of hypertension in obstructive sleep apnea. Curr Cardiol Rep 2015; 17:108.
23. Pepin JL, Tamisier R, Baguet JP, et al. Fixed pressure CPAP versus autoadjusting CPAP: comparison of efficacy on blood pressure in obstructive sleep apnoea, a randomized clinical trial. Thorax 2016. [Epub ahead of print]
24. Rajan P, Greenburg H. Obstructive sleep apnea as a risk factor for type 2 diabetes mellitus. Nat Sci Sleep 2015; 7:113-1125.
25. Shaw JE, Punjabi NM, Naughton MT, et al. The effect of treatment of obstructive sleep apnea on glycemic control in type 2 diabetes. Am J Respir Crit Care Med 2016; 194:486-492.
26. Marinez-Ceron E, Barquiel B, Bezos A-M, et al. Effect of CPAP on glycemic control in patients with obstructive sleep apnea and type 2 diabetes. A randomized clinical trial. Am J Respir Crit Care Med 2016. [Epub ahead of print]
27. Pamidi S, Wroblewski K, Stepien M, et al. Eight hours of nightly continuous positive pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. A randomized controlled trial. Am J Respir Crit Care Med 2015; 192:96-105.
28. Wang J, Yu W, Gao M, et al. Impact of obstructive sleep apnea syndrome on endothelial function, arterial stiffening and serum inflammatory markers: an updated meta-analysis and meta regression of 18 studies. J Am Heart Assoc 2015; 4: pii: e002454. doi: 10.1161/JAHA.115.002454.
29. Paz Y, Mar HL, Hazen SL, et al. Effect of continuous positive airway pressure on cardiovascular biomarkers. The Sleep Apnea Stress Randomized Controlled Trial. Chest 2016; 150:80-90.
30. Lee CH, Sethi R, Li R, et al. Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention. Circulation 2016; 133: 2008-2017.
31. Wu X, Lv S, Yu X, et al. Treatment of OSA reduces the risk of repeat revascularization after percutaneous coronary intervention. Chest 2015; 147:708-718.
32. Mazaki T, Kasai T, Yokoi H, et al. Impact of sleep-disordered breathing on long-term outcomes in patients with acute coronary syndrome who have undergone primary percutaneous coronary intervention. J Am Heart Assoc 2016; 5: pii: e003270.
33. Peker Y, Glantz H, Eulenburg C, et al. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea: The RICCADSA randomized controlled trial. Am J Respir Crit Care Med 2016; 194:613-620.
34. Holmqvist F, Guan N, Zhu Z, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J 2015; 169:647-654.e2.
35. Mullington JM, Abbott SM, Carroll JE, et al. Developing biomarker arrays predicting sleep and circadian-coupled risks to health. Sleep 2016; 39:727-736.
36. Drager LF, Polotsky VY, O'Donnell CP, et al. Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2015; 309:H1101-H1111.
37. Chopra S, Polotsky VY, Jun JC. Sleep apnea research in animals. Past, present and future. Am J Respir Cell Mol Biol 2016; 54:299-305.